Your session is about to expire
← Back to Search
rTMS for Stimulant Addiction (VA-StARTS Trial)
VA-StARTS Trial Summary
This trial will test a new treatment, repetitive transcranial stimulation (rTMS), for Veterans with stimulant use disorder (SUD). The goal is to see if rTMS is effective and to identify biomarkers that may help predict who will respond best to treatment.
VA-StARTS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowVA-StARTS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.VA-StARTS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have implants or medical devices that cannot be used with TMS (Transcranial Magnetic Stimulation).You have had a bad reaction to TMS treatment in the past.I have a severe substance use disorder diagnosis.You are currently struggling with a substance addiction and haven't been in long-term recovery.I do not have any severe illnesses that would stop me from following the study's requirements.You have taken stimulant medications within the past 1 to 6 weeks.You have a long-lasting or recurring mental health condition, other than PTSD, that happened before your substance use disorder.My health condition is stable.I am not on high-risk seizure medications like clozapine or bupropion over 400 mg/day.My IQ is above 80.I have a history of seizures or conditions that raise my seizure risk.
- Group 1: Sham rTMS
- Group 2: Active rTMS
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment permit participants below the age of thirty?
"This clinical trial has a specified age range, where those aged 18 to 65 are eligible for enrollment."
Is this clinical research currently recruiting participants?
"Affirmative. According to clinicaltrials.gov, the trial is currently seeking participants; it was first listed on February 5th 2021 and last updated on February 24th 2022. 48 individuals need to be enrolled from a single location."
To whom is this medical experiment open for enrollment?
"This study is seeking 48 volunteers, aged between 18 and 65, that have been diagnosed with a stimulants use disorder. Prerequisites for potential participants include: SCID certified SUD diagnosis of severity; abstinence from the usage of stimulants in the past 1 to 6 weeks; an unchanging medication dosages or agents over 2 weeks prior to commencement and throughout treatment phase; secured housing enabling regular visits to medical centres; aptitude for cognitive testing, fMRI scans, and rTMS (no counter-indications); IQ above 80 marks; stable physical health status as well as enrolment at Palo Alto VA's Addiction Treatment Services."
What is the aggregate patient count for this research experiment?
"Affirmative. Concerning this clinical trial, the information on clinicaltrials.gov attests to its current recruitment status; it was initially posted on February 5th 2021 and most recently updated on February 24th 2022. The study requires 48 individuals at 1 site for enrollment."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
How responsive is this trial?
Average response time
- < 1 Day
Typically responds via
Most responsive sites:
- VA Palo Alto Health Care System, Palo Alto, CA: < 24 hours
Share this study with friends
Copy Link
Messenger